Skip to main content
Springer logoLink to Springer
. 2018 May 21;12(2):273–277. doi: 10.1007/s12104-018-9822-7

Backbone NMR assignments of HypF-N under conditions generating toxic and non-toxic oligomers

Jayneil R Patel 1, Yingqi Xu 1, Claudia Capitini 2, Fabrizio Chiti 2, Alfonso De Simone 1,
PMCID: PMC6132818  PMID: 29786756

Abstract

The HypF protein is involved in the maturation and regulation of hydrogenases. The N-terminal domain of HypF (HypF-N) has served as a key model system to study the pathways of protein amyloid formation and the nature of the toxicity of pre-fibrilar protein oligomers. This domain can aggregate into two forms of oligomers having significantly different toxic effects when added to neuronal cultures. Here, NMR assignments of HypF-N backbone resonances are presented in its native state and under the conditions favouring the formation of toxic and non-toxic oligomers. The analyses of chemical shifts provide insights into the protein conformational state and the possible pathways leading to the formation of different types of oligomers.

Keywords: Biomolecular NMR, Protein assignment, HypF-N, Amyloids, Protein oligomers

Introduction

HypF plays a chaperone role in the biogenesis of nickel–iron [NiFe] insertion in hydrogenase enzymes from E. coli (Maier and Böck 1996). The structure of HypF, lacking its N-terminal acylphosphatase domain, has been previously elucidated by X-ray crystallography (Petkun et al. 2011) (PDB code: 3TSP, 3TSQ, 3TSU, 3TTD, 3TTF). The N-terminal domain of HypF (HypF-N) is a small 11 kDa α/β protein of 91 residues (Rosano et al. 2002) that is structured in a β-sheet of five strands (S1–S5) and 2 α-helices (H1 and H2) in a βαββαβ topology (PDB code: 1GXT, 1GXU) (Rosano et al. 2002). While HypF-N is not associated to any disease, it has been extensively used to elucidate the underlying biomolecular processes of neurodegenerative disorders (Chiti et al. 2001; Campioni et al. 2010; Zampagni et al. 2011). It is indeed well established that the aggregation of otherwise soluble proteins into amyloid fibrils is associated with a number of neurodegenerative conditions, including Alzheimer’s and Parkinson’s diseases, and non-neuropathic conditions such as diabetes type II (Chiti and Dobson 2017). It is now generally acknowledged that the most pernicious species along the pathways of amyloid formation are the small diffusible pre-fibrilar oligomers (Campioni et al. 2010; Fusco et al. 2017). In this context, HypF-N has unique features to enable the elucidation of the molecular basis of the toxicity of protein oligomers, as it can form two different types of protein oligomers that, while being similar in composition, shape, size and morphology, have significantly different toxic effects when incubated with cellular cultures, with only one showing toxic effects. Such a biological diversity has been attributed to the selective interaction with the cellular membrane, with only the toxic oligomers being able to penetrate the membrane and cause an influx of Ca2+ ions (Cecchi et al. 2005; Canale et al. 2006; Campioni et al. 2010; Zampagni et al. 2011). Despite the relevance of this protein in the context of amyloid diseases, the assignments of the NMR resonances of HypF-N under the conditions A and B, which respectively generate toxic and non-toxic oligomers, are not available from the BMRB. In the present work we present a detailed characterisation of the general structural properties of HypF-N in its native state and under the two oligomerising conditions. The analysis of chemical shifts clearly identifies a substantial degree of structural and dynamical differences between the protein monomers investigated under the conditions leading to toxic and non-toxic oligomers. This work will boost further high-resolution characterisations in these two states.

Methods and materials

1H, 13C, 15N, isotopically labelled HypF-N was expressed and purified as previously reported (Calloni et al. 2008), using an N-terminal His-tag construct that was expressed in the E. coli strain M15[PREP4] (Qiagen), grown in M9 minimal media by using 15N-enriched ammonium chloride and 13C-enriched glucose, and purified using a nickel column (Sigma Aldrich). The HypF-N protein was then cleaved from the nickel resin with thrombin from bovine plasma (Sigma Aldrich) overnight at 4 °C in phosphate buffer. Thrombin cleavage generates a non-native N-terminal sequence (Gly-Ser-Ala instead of Met-Ala). This construct is equivalent to that employed in the study identifying the conditions (A and B) to generate toxic and non-toxic HypF-N oligomers (Campioni et al. 2010). The eluted HypF-N was then buffer exchanged into 5 mM sodium acetate, 2 mM dithiothreitol (DTT) buffer at pH 5.5.

NMR measurements were performed on 13C, 15N labelled HypF-N samples at a concentration of 200 µM. Three independent assignments of the backbone resonances were performed, including native (5 mM sodium acetate, 2 mM DTT, 50 mM sodium phosphate pH 5.5), toxic condition A (50 mM sodium acetate, 2 mM DTT, 12% 2,2,2-trifluoroethanol (TFE) (v/v), pH 5.5) and non-toxic condition B [330 mM sodium chloride, 20 mM trifluoroacetic acid (TFA), pH 1.7]. Each sample contained 10% (v/v) D2O for the NMR lock. For the aggregation prone conditions A and B, NMR measurements were performed in a time frame corresponding to the lag phase for aggregation, which enables minimal monomer depletion from the solution. Under the conditions employed in this work, the lag phases were ~ 16 and ~ 24 h for condition A and B, respectively. Measurements of 3D NMR spectra were therefore set to be carried out within these time ranges, requiring fresh samples to be prepared for each 3D measurement.

Assignment of the backbone resonances under these three conditions was performed by a combination of 1H–15N HSQC, CBCA(CO)NH, HNCACB, HNCO, HN(CA)CO and HNHA spectra, collectively providing chemical shifts for 1Hα, 13Cα, 13Cβ, 1HN, 13CO and 15N atoms. For the non-toxic condition B, an additional HNcocaNH spectrum (Sun et al. 2005) was recorded to aid sequential assignment. NMR was performed at 25 °C using Bruker AVANCE spectrometers operating at proton frequencies of 600 or 800 MHz, both equipped with a triple resonance cryoprobe. NMR data were processed using NMRPipe (Delaglio et al. 1995) and analysed using CCPNAnalysis (Vranken et al. 2005).

Results

Under native conditions, 81 (out of 86 non-proline) 1H–15N correlations were assigned across the protein sequence (Fig. 1a). The peak dispersion in the 1H–15N-HSQC spectrum indicates that HypF-N is well-folded in its native state, as also confirmed by the RCI analysis made using δ2D (Camilloni et al. 2012) (Fig. 2a). Under condition A, the spectral properties suggest that HypF-N is structured in a native-like conformational state (Fig. 1a-b), with 1H 15N resonances close to those of the native state, except for the catalytic phosphate binding site (residues 18–24), for which no NMR resonances are detected under these conditions. Indeed, the lack of phosphate ions in the condition A likely generates a local conformational exchange that enhances the relaxation of the resonances of the loop 18–24 leading to significant peak broadening, observed in homologous acylphosphotase enzymes (Fusco et al. 2012; De Simone et al. 2011). The similarity of spectral properties between native state and condition A is also shown by the difference in chemical shifts for 13Cα and 13Cβ (Fig. 2b, c). In contrast, under condition B, HypF-N shows spectral properties that are indicative of an unfolded protein (Fig. 1c), as previously observed (Calloni et al. 2008). The assignment statistics for conditions A and B are listed in Table 1.

Fig. 1.

Fig. 1

Assigned 2D 1H–15N HSQC spectra of HypF-N recorded at 25 °C at the 1H frequency of 600 MHz. a Native state. b Condition A. c Condition B

Fig. 2.

Fig. 2

a Random coil index estimated using the population of coil regions from δ2D (Camilloni et al. 2012). Native state and aggregation prone states of HypF-N (condition A and condition B) are shown with green, red and blue lines, respectively. Lines are used to connect the data for which RCI values have been calculated based on chemical shifts. The schematic of the native protein secondary structure is shown illustrating the α-helical segments (red blocks) and β-sheet strands (blue arrows). bc) Differences between the 13Cα (b) and 13Cβ (c) chemical shifts measured for the native state and condition A of HypF-N. Data has been excluded where assignments are missing in one or both conditions

Table 1.

Number of assigned nuclei

1 13 13 13CO 15N 1HN
Nativea 79 78 81 79 81 81
Condition A 72 77 78 77 77 77
Condition B 62 78 79 78 78 78

aUnassigned or missing backbone amide resonances in the 1H–15N HSQC: Native: 1, 18, 20, 23, 24. Condition A: 1, 2, 19–24, 63. Condition B: 1, 29, 36, 43, 53 76, 80, 92

Using the chemical shift values, random coil index was calculated as the population of coil regions in δ2D (Camilloni et al. 2012) (Fig. 2a). This analysis indicates that, in contrast to the native state and condition A, showing structured and coil regions that are consistent with those identified in the X-ray structure of HypF-N (PDB code: 1GXT; Rosano et al. 2002), condition B exhibits significantly high values of RCI throughout the sequence, which is indicative of a highly flexible and disordered state.

In summary, NMR assignments of HypF-N resonances under different oligomerising conditions and in the native state have provided crucial insights into the conformational and structural properties of the protein in its physiological and aggregation-prone states. The assignments will enable further investigations to reveal the detailed mechanisms leading to the formation of toxic and nontoxic HypF-N oligomers.

The assignments have been deposited to the BMRB under the accession codes: 27139 (native), 27137 (toxic) and 27138 (non-toxic).

Acknowledgements

We acknowledge support from the Leverhulme Trust (RPG-2015-350) and the UK Biotechnology and Biological Sciences Research Council (BB/M023923/1) and Wellcome Trust (104933/Z/14/Z).

References

  1. Calloni G, Lendel C, Campioni S, Giannini S, Gliozzi A, Relini A, Vendruscolo M, Dobson CM, Salvatella X, Chiti F. Structure and dynamics of a partially folded protein are decoupled from its mechanism of aggregation. J Am Chem Soc. 2008;130:13040–13050. doi: 10.1021/ja8029224. [DOI] [PubMed] [Google Scholar]
  2. Camilloni C, De Simone A, Vranken WF, Vendruscolo M. Determination of secondary structure populations in disordered states of proteins using nuclear magnetic resonance chemical shifts. Biochemistry. 2012;51:2224–2231. doi: 10.1021/bi3001825. [DOI] [PubMed] [Google Scholar]
  3. Campioni S, Mannini B, Zampagni M, Penselfini A, Parrini C, Evangelisti E, Relini A, Stefani M, Dobson CM, Cecchi C, Chiti F. A causative link between the structure of aberrant protein oligomers and their toxicity. Nat Chem Biol. 2010;6:140–147. doi: 10.1038/nchembio.283. [DOI] [PubMed] [Google Scholar]
  4. Canale C, Torrassa S, Rispoli P, Relini A, Rolandi R, Bucciantini M, Stefani M, Gliozzi A. Natively folded HypF-N and its early amyloid aggregates interact with phospholipid monolayers and destabilize supported phospholipid bilayers. Biophys J. 2006;91(12):4575–4588. doi: 10.1529/biophysj.106.089482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cecchi C, Baglioni S, Fiorillo C, Pensalfini A, Liguri G, Nosi D, Rigacci S, Bucciantini M, Stefani M. Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates. J Cell Sci. 2005;118:3459–3470. doi: 10.1242/jcs.02473. [DOI] [PubMed] [Google Scholar]
  6. Chiti F, Dobson CM. Protein misfolding, functional amyloid and human disease. Annu Rev Biochem. 2017;75:333–366. doi: 10.1146/annurev.biochem.75.101304.123901. [DOI] [PubMed] [Google Scholar]
  7. Chiti F, Bucciantini M, Capanni C, Taddei N, Dobson CM, Stefani M. Solution conditions can promote formations of either amyloid protofilaments or mature fibrils from the HypF-N terminal domain. Protein Sci. 2001;10:2541–2547. doi: 10.1110/ps.ps.10201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. De Simone A, Dhulesia A, Soldi G, Vendruscolo M, Hsu ST, Chiti F, Dobson CM. Experimental free energy surfaces reveal the mechanisms of maintenance of protein solubility. Proc Natl Acad Sci USA. 2011;108(52):21057–21062. doi: 10.1073/pnas.1112197108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995;6(3):277–293. doi: 10.1007/BF00197809. [DOI] [PubMed] [Google Scholar]
  10. Fusco G, De Simone A, Hsu ST, Bemporad F, Vendruscolo M, Chiti F, Dobson CM. 1H, 13C and 15N resonance assignments of human muscle acylphosphatase. Biomol. NMR Assign. 2012;6(1):27–29. doi: 10.1007/s12104-011-9318-1. [DOI] [PubMed] [Google Scholar]
  11. Fusco G, Chen SW, Williamson PT, Cascella R, Perni M, Jarvis JA, Cecchi C, Vendruscolo M, Chiti F, Cremades N, Ying L, Dobson CM, De Simone A. Structural basis of the membrane disruption and cellular toxicity by α-synuclein oligomners. Science. 2017;358(6369):1440–1443. doi: 10.1126/science.aan6160. [DOI] [PubMed] [Google Scholar]
  12. Maier T, Böck A. Nickel incorporation into hydrogenases. In: Hausinger RP, Eichhorn GL, Marzilli LG, editors. Advances in inorganic biochemistry: mechanisms of metallocenter assembly. New York: VCH Publishers Inc.; 1996. pp. 173–192. [Google Scholar]
  13. Petkun S, Shi R, Li Y, Asinas A, Munger C, Zhang L, Waclawek M, Soboh B, Sawers RG, Cygler M. Structure of hydrogenase maturation protein HypF with reaction intermediates shows two active sites. Structure. 2011;19:1773–1783. doi: 10.1016/j.str.2011.09.023. [DOI] [PubMed] [Google Scholar]
  14. Rosano C, Zuccotti S, Bucciantini M, Stefani M, Rampioni G, Bolognesi M. Crystal structure and anion binding in the prokaryotic hydrogenase maturation factor HypF acylphosphatase-like domain. J Mol Biol. 2002;321:785–796. doi: 10.1016/S0022-2836(02)00713-1. [DOI] [PubMed] [Google Scholar]
  15. Sun ZY, Frueh DP, Selenko P, Hoch JC, Wagner G. Fast assignment of 15N-HSQC peaks using high-resolution 3D HNcocaNH experiments with non-uniform sampling. J Biomol NMR. 2005;33:43–50. doi: 10.1007/s10858-005-1284-4. [DOI] [PubMed] [Google Scholar]
  16. Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, Laue ED. The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins. 2005;59:687–696. doi: 10.1002/prot.20449. [DOI] [PubMed] [Google Scholar]
  17. Zampagni M, Cascella R, Casamenti F, Grossi C, Evangelisti E, Wright D, Becatti M, Liguri G, Mannini B, Campioni S, Chiti F, Cecchi C. A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells. J Cell Mol Med. 2011;15(10):2106–2116. doi: 10.1111/j.1582-4934.2010.01239.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biomolecular Nmr Assignments are provided here courtesy of Springer

RESOURCES